120 related articles for article (PubMed ID: 15513363)
1. Prognostic relevance of 20q13 gains in sporadic colorectal cancers: a FISH analysis.
Aust DE; Muders M; Köhler A; Schmidt M; Diebold J; Müller C; Löhrs U; Waldman FM; Baretton GB
Scand J Gastroenterol; 2004 Aug; 39(8):766-72. PubMed ID: 15513363
[TBL] [Abstract][Full Text] [Related]
2. 20q13 and cyclin D1 in ovarian carcinomas. Analysis by fluorescence in situ hybridization.
Diebold J; Mösinger K; Peiro G; Pannekamp U; Kaltz C; Baretton GB; Meier W; Löhrs U
J Pathol; 2000 Apr; 190(5):564-71. PubMed ID: 10727982
[TBL] [Abstract][Full Text] [Related]
3. Association of 20q13.2 copy number changes with the advanced stage of ovarian cancer-tissue microarray analysis.
Dimova I; Yosifova A; Zaharieva B; Raitcheva S; Doganov N; Toncheva D
Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):81-5. PubMed ID: 15596278
[TBL] [Abstract][Full Text] [Related]
4. Numerical abnormalities of chromosomes 17 and 18 in sporadic colorectal cancer: Incidence and correlation with clinical and biological findings and the prognosis of the disease.
Garcia J; Duran A; Tabernero MD; Garcia Plaza A; Flores Corral T; Najera ML; Gomez-Alonso A; Orfao A
Cytometry B Clin Cytom; 2003 Jan; 51(1):14-20. PubMed ID: 12500293
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 20q13.2 gain may predict intravesical recurrence after nephroureterectomy in upper urinary tract urothelial tumors.
Akao J; Matsuyama H; Yamamoto Y; Sasaki K; Naito K
Clin Cancer Res; 2006 Dec; 12(23):7004-8. PubMed ID: 17145821
[TBL] [Abstract][Full Text] [Related]
6. Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications.
Tanner MM; Tirkkonen M; Kallioniemi A; Holli K; Collins C; Kowbel D; Gray JW; Kallioniemi OP; Isola J
Clin Cancer Res; 1995 Dec; 1(12):1455-61. PubMed ID: 9815944
[TBL] [Abstract][Full Text] [Related]
7. CAS (cellular apoptosis susceptibility) gene expression in ovarian carcinoma: Correlation with 20q13.2 copy number and cyclin D1, p53, and Rb protein expression.
Peiró G; Diebold J; Löhrs U
Am J Clin Pathol; 2002 Dec; 118(6):922-9. PubMed ID: 12472286
[TBL] [Abstract][Full Text] [Related]
8. Differences in 20q13.2 copy number between colorectal cancers with and without liver metastasis.
Hidaka S; Yasutake T; Takeshita H; Kondo M; Tsuji T; Nanashima A; Sawai T; Yamaguchi H; Nakagoe T; Ayabe H; Tagawa Y
Clin Cancer Res; 2000 Jul; 6(7):2712-7. PubMed ID: 10914715
[TBL] [Abstract][Full Text] [Related]
9. 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells.
Savelieva E; Belair CD; Newton MA; DeVries S; Gray JW; Waldman F; Reznikoff CA
Oncogene; 1997 Feb; 14(5):551-60. PubMed ID: 9053853
[TBL] [Abstract][Full Text] [Related]
10. Prognosis and gene expression profiling of 20q13-amplified breast cancers.
Ginestier C; Cervera N; Finetti P; Esteyries S; Esterni B; Adélaïde J; Xerri L; Viens P; Jacquemier J; Charafe-Jauffret E; Chaffanet M; Birnbaum D; Bertucci F
Clin Cancer Res; 2006 Aug; 12(15):4533-44. PubMed ID: 16899599
[TBL] [Abstract][Full Text] [Related]
11. Frequent PIK3CA gene amplification and its clinical significance in colorectal cancer.
Jehan Z; Bavi P; Sultana M; Abubaker J; Bu R; Hussain A; Alsbeih G; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
J Pathol; 2009 Nov; 219(3):337-46. PubMed ID: 19697359
[TBL] [Abstract][Full Text] [Related]
12. Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer.
Yamamoto Y; Matsuyama H; Furuya T; Oga A; Yoshihiro S; Okuda M; Kawauchi S; Sasaki K; Naito K
Clin Cancer Res; 2004 Oct; 10(19):6449-55. PubMed ID: 15475431
[TBL] [Abstract][Full Text] [Related]
13. 20q11.1 amplification in giant-cell tumor of bone: Array CGH, FISH, and association with outcome.
Smith LT; Mayerson J; Nowak NJ; Suster D; Mohammed N; Long S; Auer H; Jones S; McKeegan C; Young G; Bos G; Plass C; Morrison C
Genes Chromosomes Cancer; 2006 Oct; 45(10):957-66. PubMed ID: 16847944
[TBL] [Abstract][Full Text] [Related]
14. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
[TBL] [Abstract][Full Text] [Related]
15. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.
Chang SC; Lin JK; Lin TC; Liang WY
Int J Oncol; 2005 Jan; 26(1):65-75. PubMed ID: 15586226
[TBL] [Abstract][Full Text] [Related]
16. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
[TBL] [Abstract][Full Text] [Related]
17. 8q gain is an independent predictor of poor survival in diagnostic needle biopsies from prostate cancer suspects.
Ribeiro FR; Jerónimo C; Henrique R; Fonseca D; Oliveira J; Lothe RA; Teixeira MR
Clin Cancer Res; 2006 Jul; 12(13):3961-70. PubMed ID: 16818693
[TBL] [Abstract][Full Text] [Related]
18. Prognostic utility of fluorescence in situ hybridization for determining HER2 gene amplification in breast cancer.
Kammori M; Kurabayashi R; Kashio M; Sakamoto A; Yoshimoto M; Amano S; Kaminishi M; Yamada T; Takubo K
Oncol Rep; 2008 Mar; 19(3):651-6. PubMed ID: 18288397
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer.
Jensen SA; Vainer B; Witton CJ; Jørgensen JT; Sørensen JB
Acta Oncol; 2008; 47(6):1054-61. PubMed ID: 18607850
[TBL] [Abstract][Full Text] [Related]
20. Protein expression and gene copy number analysis of topoisomerase 2alpha, HER2 and P53 in minimally invasive urothelial carcinoma of the urinary bladder--a multitissue array study with prognostic implications.
Krüger S; Lange I; Kausch I; Feller AC
Anticancer Res; 2005; 25(1A):263-71. PubMed ID: 15816547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
